Andrea Boutros

918 total citations · 1 hit paper
32 papers, 540 citations indexed

About

Andrea Boutros is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Andrea Boutros has authored 32 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Andrea Boutros's work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (9 papers) and Melanoma and MAPK Pathways (8 papers). Andrea Boutros is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (9 papers) and Melanoma and MAPK Pathways (8 papers). Andrea Boutros collaborates with scholars based in Italy, Australia and United States. Andrea Boutros's co-authors include Francesco Spagnolo, Enrica T. Tanda, Paola Queirolo, Luca Arecco, Pietro Quaglino, Matteo Lambertini, William Bruno, Irene Vanni, Paola Ghiorzo and Virginia Andreotti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Andrea Boutros

27 papers receiving 536 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The treatment of advanced melanoma: Current approaches and new challenges

2024 50 citations Andrea Boutros, Marco Ferrari et al. Critical Reviews in Oncology/Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Boutros Italy	15	340	181	125	69	61	32	540
Silverio Tomao Italy	13	253 0.7×	177 1.0×	84 0.7×	68 1.0×	60 1.0×	23	506
Djura Piersma Netherlands	15	338 1.0×	200 1.1×	97 0.8×	158 2.3×	51 0.8×	50	649
Meng Ma China	15	178 0.5×	302 1.7×	66 0.5×	22 0.3×	72 1.2×	40	530
Alice N. Weaver United States	12	267 0.8×	287 1.6×	44 0.4×	52 0.8×	63 1.0×	26	590
Hélio Humberto Angotti Carrara Brazil	14	188 0.6×	158 0.9×	73 0.6×	45 0.7×	66 1.1×	53	544
Rafael Ríos Spain	12	171 0.5×	244 1.3×	69 0.6×	26 0.4×	28 0.5×	39	543
Simona Scalone Italy	16	410 1.2×	207 1.1×	91 0.7×	13 0.2×	109 1.8×	55	784
Francesco Paolo Fiorentino Italy	13	176 0.5×	346 1.9×	36 0.3×	37 0.5×	60 1.0×	20	573
Brittney S. Harrington Australia	10	132 0.4×	211 1.2×	56 0.4×	21 0.3×	37 0.6×	19	393

Countries citing papers authored by Andrea Boutros

Since Specialization

Citations

This map shows the geographic impact of Andrea Boutros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Boutros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Boutros more than expected).

Fields of papers citing papers by Andrea Boutros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Boutros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Boutros. The network helps show where Andrea Boutros may publish in the future.

Co-authorship network of co-authors of Andrea Boutros

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Boutros. A scholar is included among the top collaborators of Andrea Boutros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Boutros. Andrea Boutros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanda, Enrica T., Albino Claudio Bosio, Giovanni A. Rossi, et al.. (2025). Melanoma-specific risk associated with hormone replacement therapy and fertility treatments: A narrative review and a clinical guide. SHILAP Revista de lepidopterología. 3. 100741–100741.

Barisione, Emanuela, Andrea Boutros, Marco Mora, et al.. (2024). Primary endobronchial melanoma: a case report and clinical management indications. BMC Pulmonary Medicine. 24(1). 97–97. 1 indexed citations

Queirolo, Paola, Michela Cinquini, Giuseppe Argenziano, et al.. (2024). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. ESMO Open. 9(5). 103005–103005. 5 indexed citations

Boutros, Andrea, Marco Ferrari, Giulia Massaro, et al.. (2024). The treatment of advanced melanoma: Current approaches and new challenges. Critical Reviews in Oncology/Hematology. 196. 104276–104276. 50 indexed citations breakdown →

Boutros, Andrea, Roberta Carosio, Barbara Banelli, et al.. (2024). Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma. Archives of Dermatological Research. 316(7). 414–414.

Boutros, Andrea, Matteo S. Carlino, & Alexander M. Menzies. (2024). Melanoma medicine: New drugs for melanoma and the role of the general practitioner. Australian Journal of General Practice. 53(9). 619–624.

Queirolo, Paola, Michela Cinquini, Giuseppe Argenziano, et al.. (2023). Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. ESMO Open. 8(6). 102037–102037. 8 indexed citations

Boutros, Andrea, Enrica T. Tanda, Fabio Catalano, et al.. (2023). Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis. European Journal of Cancer. 188. 64–79. 24 indexed citations

Boutros, Andrea, Roberta Carosio, Francesco Spagnolo, et al.. (2023). The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors. Immuno-Oncology Technology. 20. 100408–100408. 3 indexed citations

10.

Boutros, Andrea, Enrica T. Tanda, Luca Arecco, et al.. (2023). Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma. Journal of Geriatric Oncology. 15(2). 101640–101640. 2 indexed citations

11.

Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2022). Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Human Reproduction. 37(5). 954–968. 61 indexed citations

12.

Boutros, Andrea, Lara Vera, Federico Gatto, Giuseppe Fornarini, & Elisa Zanardi. (2022). Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients. Frontiers in Oncology. 12. 1048526–1048526. 1 indexed citations

13.

Boutros, Andrea, Enrica T. Tanda, Fabio Catalano, et al.. (2022). Activity and Safety of First-Line Treatments for Advanced Melanoma: A Network Meta-Analysis. SSRN Electronic Journal. 2 indexed citations

14.

Arecco, Luca, Valentino Martelli, Andrea Boutros, et al.. (2021). How to Protect Ovarian Function before and during Chemotherapy?. Journal of Clinical Medicine. 10(18). 4192–4192. 20 indexed citations

15.

Boutros, Andrea, Marco Bruzzone, Enrica T. Tanda, et al.. (2021). 1687P Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomized controlled trials: A systematic review and meta-analysis. Annals of Oncology. 32. S1180–S1181. 1 indexed citations

16.

Tanda, Enrica T., Irene Vanni, Andrea Boutros, et al.. (2020). Current State of Target Treatment in BRAF Mutated Melanoma. Frontiers in Molecular Biosciences. 7. 154–154. 73 indexed citations

17.

Vanni, Irene, Enrica T. Tanda, Bruna Dalmasso, et al.. (2020). Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications. Frontiers in Molecular Biosciences. 7. 172–172. 25 indexed citations

18.

Mastracci, Luca, Vincenzo Fontana, Paola Queirolo, et al.. (2020). Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization. Cancer Immunology Immunotherapy. 69(4). 653–662. 16 indexed citations

19.

Queirolo, Paola, Andrea Boutros, Enrica T. Tanda, Francesco Spagnolo, & Pietro Quaglino. (2019). Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy. Seminars in Cancer Biology. 59. 290–297. 71 indexed citations

20.

Spagnolo, Francesco, Andrea Boutros, Enrica T. Tanda, & Paola Queirolo. (2019). The adjuvant treatment revolution for high-risk melanoma patients. Seminars in Cancer Biology. 59. 283–289. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact